Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

IRWD Relative to the S&P 500

IRWD Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Ironwood Pharmaceuticals Inc. (NASD:IRWD) seasonal charts above shows that a Buy Date of October 10 and a Sell Date of December 29 has resulted in a geometric average return of 3.26% above the benchmark rate of the S&P 500 Total Return Index over the past 15 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 15 years by an average of 22.01% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

To download IRWD seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: IRWD